CellaVision AB
OTC:CLVSF
CellaVision AB
OTC:CLVSF
Price:
15.85
USD
Market Closed
Market Cap:
$378m
Balance Sheet
Balance Sheet Decomposition
CellaVision AB
CellaVision AB
Balance Sheet Decomposition is not available for
CellaVision AB
CellaVision AB
Balance Sheet
CellaVision AB
CellaVision AB
Currency: SEK
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
39
|
5
|
19
|
18
|
17
|
16
|
20
|
22
|
36
|
57
|
46
|
58
|
52
|
107
|
132
|
155
|
169
|
102
|
102
|
130
|
108
|
122
|
149
|
188
|
|
| Cash |
39
|
5
|
19
|
18
|
17
|
16
|
20
|
22
|
36
|
57
|
46
|
58
|
52
|
107
|
132
|
155
|
169
|
102
|
102
|
130
|
108
|
122
|
149
|
188
|
|
| Total Receivables |
5
|
5
|
9
|
11
|
14
|
14
|
38
|
30
|
41
|
32
|
48
|
48
|
68
|
42
|
42
|
50
|
84
|
103
|
106
|
114
|
120
|
110
|
122
|
141
|
|
| Accounts Receivables |
4
|
5
|
6
|
9
|
11
|
12
|
33
|
26
|
35
|
27
|
41
|
43
|
61
|
35
|
33
|
43
|
76
|
89
|
71
|
90
|
98
|
98
|
103
|
120
|
|
| Other Receivables |
1
|
1
|
3
|
2
|
2
|
3
|
5
|
5
|
6
|
6
|
8
|
5
|
7
|
6
|
9
|
7
|
8
|
14
|
35
|
24
|
22
|
12
|
19
|
21
|
|
| Inventory |
8
|
7
|
9
|
14
|
7
|
4
|
8
|
9
|
8
|
15
|
16
|
17
|
25
|
25
|
36
|
29
|
34
|
55
|
84
|
115
|
143
|
126
|
125
|
112
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
5
|
4
|
5
|
6
|
7
|
5
|
6
|
5
|
7
|
8
|
7
|
0
|
|
| Total Current Assets |
53
|
18
|
38
|
43
|
39
|
36
|
67
|
62
|
85
|
106
|
114
|
126
|
149
|
177
|
216
|
239
|
295
|
265
|
298
|
365
|
377
|
366
|
403
|
441
|
|
| PP&E Net |
4
|
4
|
2
|
1
|
1
|
1
|
3
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
5
|
7
|
54
|
47
|
80
|
110
|
126
|
120
|
122
|
|
| PP&E Gross |
4
|
4
|
2
|
1
|
1
|
1
|
3
|
2
|
2
|
2
|
3
|
0
|
3
|
3
|
3
|
5
|
7
|
54
|
47
|
80
|
110
|
126
|
120
|
0
|
|
| Accumulated Depreciation |
5
|
6
|
7
|
8
|
10
|
8
|
9
|
10
|
10
|
11
|
13
|
0
|
15
|
3
|
4
|
5
|
7
|
30
|
44
|
59
|
72
|
91
|
111
|
0
|
|
| Intangible Assets |
11
|
8
|
5
|
1
|
1
|
7
|
15
|
23
|
22
|
21
|
24
|
27
|
27
|
29
|
35
|
54
|
68
|
185
|
189
|
244
|
275
|
309
|
360
|
529
|
|
| Goodwill |
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
115
|
112
|
114
|
124
|
124
|
128
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
4
|
22
|
22
|
22
|
5
|
4
|
3
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
0
|
0
|
12
|
26
|
53
|
49
|
38
|
33
|
23
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
115
|
112
|
114
|
124
|
124
|
128
|
0
|
|
| Total Assets |
74
N/A
|
31
-59%
|
45
+48%
|
46
+2%
|
41
-11%
|
44
+7%
|
97
+119%
|
113
+18%
|
163
+43%
|
179
+10%
|
179
0%
|
189
+6%
|
202
+7%
|
220
+9%
|
256
+16%
|
301
+17%
|
373
+24%
|
642
+72%
|
668
+4%
|
825
+24%
|
892
+8%
|
929
+4%
|
1 013
+9%
|
1 095
+8%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
3
|
2
|
4
|
3
|
8
|
6
|
17
|
14
|
11
|
17
|
17
|
11
|
12
|
7
|
16
|
21
|
27
|
22
|
21
|
45
|
48
|
33
|
32
|
36
|
|
| Accrued Liabilities |
3
|
3
|
3
|
3
|
3
|
3
|
4
|
6
|
11
|
15
|
16
|
18
|
26
|
27
|
28
|
22
|
35
|
44
|
30
|
37
|
38
|
46
|
58
|
0
|
|
| Short-Term Debt |
1
|
2
|
7
|
9
|
7
|
8
|
21
|
14
|
20
|
15
|
14
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
51
|
46
|
41
|
42
|
36
|
14
|
14
|
|
| Other Current Liabilities |
4
|
2
|
2
|
3
|
4
|
7
|
9
|
5
|
6
|
5
|
7
|
7
|
12
|
2
|
5
|
8
|
10
|
9
|
7
|
12
|
5
|
5
|
5
|
62
|
|
| Total Current Liabilities |
11
|
9
|
16
|
18
|
22
|
24
|
51
|
39
|
49
|
53
|
54
|
56
|
51
|
37
|
49
|
51
|
72
|
126
|
104
|
135
|
133
|
119
|
109
|
111
|
|
| Long-Term Debt |
14
|
13
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
123
|
87
|
96
|
60
|
29
|
13
|
12
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
8
|
39
|
43
|
48
|
53
|
60
|
69
|
79
|
|
| Other Liabilities |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
6
|
4
|
4
|
4
|
5
|
6
|
5
|
|
| Total Liabilities |
25
N/A
|
23
-10%
|
27
+20%
|
20
-27%
|
24
+20%
|
24
+2%
|
51
+110%
|
39
-24%
|
49
+27%
|
53
+7%
|
54
+2%
|
56
+5%
|
51
-9%
|
37
-28%
|
50
+36%
|
60
+19%
|
82
+38%
|
293
+256%
|
238
-19%
|
282
+18%
|
250
-11%
|
212
-15%
|
197
-7%
|
207
+5%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
2
|
2
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
0
|
|
| Retained Earnings |
47
|
51
|
33
|
19
|
9
|
3
|
32
|
60
|
99
|
112
|
108
|
118
|
137
|
169
|
192
|
224
|
277
|
340
|
429
|
537
|
608
|
685
|
772
|
0
|
|
| Additional Paid In Capital |
0
|
57
|
48
|
42
|
23
|
14
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
0
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
2
|
1
|
6
|
14
|
8
|
19
|
17
|
29
|
888
|
|
| Total Equity |
49
N/A
|
8
-83%
|
18
+123%
|
27
+47%
|
18
-33%
|
20
+14%
|
46
+129%
|
75
+63%
|
113
+52%
|
126
+11%
|
125
-1%
|
133
+6%
|
151
+14%
|
184
+21%
|
206
+12%
|
241
+17%
|
290
+21%
|
348
+20%
|
430
+23%
|
543
+26%
|
642
+18%
|
716
+12%
|
816
+14%
|
888
+9%
|
|
| Total Liabilities & Equity |
74
N/A
|
31
-59%
|
45
+48%
|
46
+2%
|
41
-11%
|
44
+7%
|
97
+119%
|
113
+18%
|
163
+43%
|
179
+10%
|
179
0%
|
189
+6%
|
202
+7%
|
220
+9%
|
256
+16%
|
301
+17%
|
373
+24%
|
642
+72%
|
668
+4%
|
825
+24%
|
892
+8%
|
929
+4%
|
1 013
+9%
|
1 095
+8%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
14
|
14
|
20
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
|
Switch to:
Switch to:
See Also
Discover More
